MiMedx Group Competitors and Similar CompaniesClear all
MiMedx Group's competitors and similar companies include Corinth MedTech and Launch Diagnostics.
 MiMedx Group MiMedx Group is a distributor and marketer of innovative bioactive healing products for tissue regeneration. |  Corinth MedTech Corinth MedTech is a healthcare company developing technology systems for the treatment of benign prostatic hyperplasia and transurethral resection of bladder tumor. |  Launch Diagnostics Launch Diagnostics is an independent distributor providing diagnostic reagents and instrumentation. | |
Founding Date | Founding Date 2008 | Founding Date 2014 | Founding Date 1990 |
Type | Type Public | Type Private | Type Private |
Tags | |||
Locations | Locations Marietta, US HQ | Locations San Jose, US HQ | Locations New Ash Green, GB HQ Paris, FR |
Employees | Employees 6968% decrease | Employees 736% decrease | Employees 465% increase |
Financial | |||
Revenue (est.) | Revenue (est.) $418.6m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) £16.6m (FY, 2018) |
Cost of goods | Cost of goods $73m (FY, 2025) | Cost of goods N/A | Cost of goods £10.4m (FY, 2018) |
Gross profit | Gross profit $345.6m (FY, 2025) | Gross profit N/A | Gross profit £6.2m (FY, 2018) |
Net income | Net income $48.6m (FY, 2025) | Net income N/A | Net income £746.2k (FY, 2018) |
Funding | |||
Total funding raised | Total funding raised $ 36.8m | Total funding raised $ 12m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Corinth MedTech
HQ
San Jose, US
Employees
7↓ 36% decrease
Corinth MedTech is a healthcare company developing technology systems for the treatment of benign prostatic hyperplasia and transurethral resection of bladder tumor.
View companyLaunch Diagnostics
HQ
New Ash Green, GB
Employees
46↑ 5% increase
Launch Diagnostics is an independent distributor providing diagnostic reagents and instrumentation.
View company